ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Holleb To Retire In June As ACS Vice President; Consensus Conference On Neurofibromatosis Set

January 23, 1987

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

DCT Board Approves New Imaging Study In Split Vote, Small Grant Program

October 27, 1989

In Brief: OMB tells NCI Mislead Congress, Refuses Higher Budget; Ford Says He Support Program

March 28, 1975

Committee Kills Pay Raise Bill; Rauscher Probably Will Resign

September 17, 1976